πŸ‡ΊπŸ‡Έ FDA
Patent

US 7420084

Polymorphic forms of nateglinide

granted A61KA61K31/16A61K31/198

Quick answer

US patent 7420084 (Polymorphic forms of nateglinide) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/16, A61K31/198